论文部分内容阅读
目的探讨米非司酮在围绝经期妇女取宫内节育器(IUD)中的价值。方法将81例在本站行IUD取出的围绝经期妇女按自愿的原则分为对照组30例和用药组51例,对照组按传统方法,用药组则在取环前两天开始服药,上午8时口服50mg,晚8时口服25mg,连续服药两天,服药前后2h禁食,第3d返院取环。比较两组的取环情况。结果两组一次性取器成功率、取器困难率、取器失败率及手术时间比较用药组显著优于对照组,差异有统计学意义(P<0.05)。用药组宫颈软化良好率及阴道壁弹性良好率显著高于对照组(P<0.05),差异有统计学意义(P<0.05)。结论米非司酮用于围绝经期妇女取环可改善宫颈条件,减少取环难度,提高取环成功率。
Objective To investigate the value of mifepristone in the treatment of IUD in perimenopausal women. Methods According to the principle of voluntariness, 81 cases of perimenopausal women who took out IUD in our hospital were divided into control group (n = 30) and medication group (n = 51). According to the traditional method, the control group took medication two days before taking the ring, 8 orally 50mg, 8 o’clock orally 25mg, two consecutive days of medication, fasting 2h before and after taking the first three days to take the hospital ring. Compare the two groups take the ring situation. Results The success rate of one-time take-up, the difficulty of taking equipment, the failure rate of taking-off device and the operation time in two groups were significantly better than those in the control group (P <0.05). The good rate of cervix softening and the good rate of vaginal wall elasticity in the medication group were significantly higher than those in the control group (P <0.05), the difference was statistically significant (P <0.05). Conclusion The use of mifepristone for perimenopausal women can improve cervical conditions, reduce the difficulty of taking the ring and improve the success rate of the ring.